143 related articles for article (PubMed ID: 2078969)
1. Preservatives in ophthalmic topical medications: a significant cause of disease.
Olson RJ; White GL
Cornea; 1990 Oct; 9(4):363-4. PubMed ID: 2078969
[No Abstract] [Full Text] [Related]
2. [Antiglaucoma drops--with or without preservatives].
Zemba M
Oftalmologia; 2009; 53(2):26-30. PubMed ID: 19697836
[TBL] [Abstract][Full Text] [Related]
3. Unilateral drug-induced ocular pseudopemphigoid.
Gibran SK
Eye (Lond); 2004 Dec; 18(12):1270. PubMed ID: 15044940
[No Abstract] [Full Text] [Related]
4. [Glaucoma and ocular surface].
Stefan C; Cojocaru I; Pop A
Oftalmologia; 2011; 55(1):30-3. PubMed ID: 21774383
[TBL] [Abstract][Full Text] [Related]
5. [Preservatives in ophthalmology].
Messmer EM
Ophthalmologe; 2012 Nov; 109(11):1064-70. PubMed ID: 23179809
[TBL] [Abstract][Full Text] [Related]
6. Contact dermatitis caused by allergy to ophthalmic drugs and contact lens solutions.
Herbst RA; Maibach HI
Contact Dermatitis; 1991 Nov; 25(5):305-12. PubMed ID: 1809533
[TBL] [Abstract][Full Text] [Related]
7. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
Baudouin C
Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
[TBL] [Abstract][Full Text] [Related]
8. Allergy to ophthalmic preservatives.
Hong J; Bielory L
Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):447-53. PubMed ID: 19697451
[TBL] [Abstract][Full Text] [Related]
9. [The deleterious effect of certain surface active agents on the ocular surface].
Ravet O
Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
[TBL] [Abstract][Full Text] [Related]
10. [Incidence of hypersensitivity to antibiotics and preservatives in eye drops].
Rudzki E; Kecik T; Portacha L; Rebandel P; Pauk M
Klin Oczna; 1995; 97(3-4):66-7. PubMed ID: 7474796
[TBL] [Abstract][Full Text] [Related]
11. [Contact allergy following administration of ophthalmic solutions and ointments].
Kruyswijk MR; Polak BC
Ned Tijdschr Geneeskd; 1980 Aug; 124(35):1449-52. PubMed ID: 6447837
[No Abstract] [Full Text] [Related]
12. Ophthalmic preservatives: focus on polyquaternium-1.
Rolando M; Crider JY; Kahook MY
Expert Opin Drug Deliv; 2011 Nov; 8(11):1425-38. PubMed ID: 21905766
[TBL] [Abstract][Full Text] [Related]
13. Are preservatives necessary to improve efficacy of some glaucoma drops?
Irkec M; Bozkurt B; Mocan MC
Br J Ophthalmol; 2013 Dec; 97(12):1493-4. PubMed ID: 24216677
[No Abstract] [Full Text] [Related]
14. The role of benzalkonium chloride in the occurrence of punctate keratitis: a meta-analysis of randomized, controlled clinical trials.
Trocme S; Hwang LJ; Bean GW; Sultan MB
Ann Pharmacother; 2010 Dec; 44(12):1914-21. PubMed ID: 21119099
[TBL] [Abstract][Full Text] [Related]
15. Issues in the use of preservative-free topicals.
Perry HD; Donnenfeld ED
Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113
[TBL] [Abstract][Full Text] [Related]
16. [A correct understanding of preservatives in eye drops].
Liu Z; Huang C
Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):641-4. PubMed ID: 26693647
[TBL] [Abstract][Full Text] [Related]
17. PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.
Coroi MC; Bungau S; Tit M
Rom J Ophthalmol; 2015; 59(1):2-5. PubMed ID: 27373107
[TBL] [Abstract][Full Text] [Related]
18. Effect of ophthalmic preservatives on serum concentration and local irritation of ocularly applied insulin.
Sasaki H; Tei C; Nishida K; Nakamura J
Biol Pharm Bull; 1995 Jan; 18(1):169-71. PubMed ID: 7735235
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?
Baudouin C
Int J Clin Pharmacol Res; 1996; 16(1):29-41. PubMed ID: 9001927
[TBL] [Abstract][Full Text] [Related]
20. Hydrogel lens solutions.
Josephson JE; Caffery BE
Int Ophthalmol Clin; 1981; 21(2):163-71. PubMed ID: 6972369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
